<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04159831</url>
  </required_header>
  <id_info>
    <org_study_id>LTI-01-2001</org_study_id>
    <nct_id>NCT04159831</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions</brief_title>
  <official_title>A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-ranging Study Evaluating LTI-01 (Single-chain Urokinase Plasminogen Activator, scuPA) in Patients With Infected, Non-draining Pleural Effusions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lung Therapeutics, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lung Therapeutics, Inc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The LTI-01-2001 study is a double-blind, placebo-controlled, Phase 2 study to evaluate LTI-01&#xD;
      (single-chain urokinase plasminogen activator, scuPA) in patients with infected, non-draining&#xD;
      pleural effusions.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 26, 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of referral to surgery</measure>
    <time_frame>Post treatment (Day 4/Hospital discharge or at time of treatment failure)</time_frame>
    <description>Treatment failure, as evidenced by continued or worsening pleural sepsis and failure to adequately drain pleural effusion, resulting in referral to surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Relative change in pleural opacity</measure>
    <time_frame>Post treatment (Day 4 or at time of treatment failure)</time_frame>
    <description>Change from baseline in absolute pleural opacity and relative change from baseline in pleural opacity volume assessed by chest CT at Day 4</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Pleural Effusion</condition>
  <arm_group>
    <arm_group_label>400,000 U LTI-01</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400,000 U LTI-01 qd x 3 days administered intrapleurally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>800,000 U LTI-01</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>800,000 U LTI-01 qd x 3 days administered intrapleurally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1,200,000 U LTI-01</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1,200,000 U LTI-01 qd x 3 days administered intrapleurally</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo (normal saline) 6ml qd x 3 days administered intrapleurally</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LTI-01</intervention_name>
    <description>single-chain urokinase plasminogen activator, scuPA</description>
    <arm_group_label>1,200,000 U LTI-01</arm_group_label>
    <arm_group_label>400,000 U LTI-01</arm_group_label>
    <arm_group_label>800,000 U LTI-01</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>normal saline</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:&#xD;
&#xD;
          -  Male or female ≥ 18 years of age who provide written informed consent&#xD;
&#xD;
          -  Clinical presentation compatible with complicated parapneumonic pleural effusion&#xD;
             (CPE), empyema or other type of pleural infection&#xD;
&#xD;
          -  Has pleural fluid requiring drainage as determined by chest ultrasonography or by&#xD;
             chest CT, and which is either:&#xD;
&#xD;
          -  a) purulent; b) gram stain positive; c) culture positive; d) pH &lt; 7.2; or e) glucose &lt;&#xD;
             60 mg/dL (3.3 mmol/L)&#xD;
&#xD;
          -  Failure to adequately drain pleural fluid ≥ 3 hours post insertion of patent chest&#xD;
             tube within the pleural space, as evidenced by one or more of the following criteria:&#xD;
&#xD;
          -  &gt; 2 cm depth of fluid by ultrasound or CT&#xD;
&#xD;
          -  &lt; 80% drainage from chest radiograph obtained prior to chest tube insertion.&#xD;
&#xD;
        Key Exclusion Criteria:&#xD;
&#xD;
          -  Current pleural infection already treated with intrapleural fibrinolytic therapy&#xD;
&#xD;
          -  Evidence of ipsilateral fibrothorax (e.g. CT scan with &gt; 0.5 cm visceral pleural&#xD;
             thickening)&#xD;
&#xD;
          -  History of multiple thoracenteses or thoracic surgical procedures within 3 months of&#xD;
             screening&#xD;
&#xD;
          -  Previous pneumonectomy on the side of the pleural effusion&#xD;
&#xD;
          -  Current bilateral pleural infections&#xD;
&#xD;
          -  Known non-expandable lung prior to this pleural infection&#xD;
&#xD;
          -  Known or high clinical suspicion of a malignant pleural effusion&#xD;
&#xD;
          -  Existing indwelling or tunneled pleural catheter&#xD;
&#xD;
          -  Current infected hepatic hydrothorax or evidence of another abdominal process (e.g.&#xD;
             pancreatic cyst or renal cyst) communicating with the pleural space&#xD;
&#xD;
          -  Active bleeding, or any condition in which bleeding is either a significant risk or&#xD;
             would be difficult to manage&#xD;
&#xD;
          -  Fully anticoagulated patients on heparin, warfarin or novel oral anti-coagulants who&#xD;
             are not able to temporarily discontinue anti-coagulants while receiving study&#xD;
             medication and for 2 days after last dose of study medication Note: patients receiving&#xD;
             low-molecular weight heparin for immobilization or anti-platelet agents are not&#xD;
             excluded.&#xD;
&#xD;
          -  Presence of severe metabolic derangements that would interfere with study assessments&#xD;
&#xD;
          -  Systolic blood pressure &gt;185 mmHg or diastolic blood pressure &gt; 110 mmHg at screening&#xD;
&#xD;
          -  Hemodynamically unstable and/or requires use of intravenous vasopressor therapy&#xD;
&#xD;
          -  Expected survival &lt; 3 months from a pathology other than the qualifying infected,&#xD;
             non-draining pleural effusion (e.g. metastatic lung carcinoma)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laura Emery, MPSH</last_name>
    <phone>303-902-6308</phone>
    <email>lemery@lungtx.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne Kinney, MSPH</last_name>
    <phone>720-470-4743</phone>
    <email>akinney@lungtx.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Abimbola Samuel Akinseye-Kolapo</last_name>
      <phone>205-934-9282</phone>
    </contact>
    <contact_backup>
      <last_name>Elizabeth Westfall</last_name>
      <phone>205.934.9282</phone>
    </contact_backup>
    <investigator>
      <last_name>Hitesh Batra, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC San Diego Health Jacobs Medical Center</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Mielke</last_name>
      <phone>619-471-0822</phone>
    </contact>
    <investigator>
      <last_name>George Cheng, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California (UCLA)</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lloyd Liang</last_name>
      <phone>310-267-1812</phone>
    </contact>
    <investigator>
      <last_name>Catherine Oberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Group</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erin Hardy</last_name>
      <phone>916-734-3866</phone>
    </contact>
    <investigator>
      <last_name>Namita Sood</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80445</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Stumph</last_name>
      <phone>303-724-6052</phone>
    </contact>
    <investigator>
      <last_name>Ali Musani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zubaida Dabre</last_name>
      <phone>203-737-5403</phone>
    </contact>
    <investigator>
      <last_name>Jonathan Puchalski, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Joyce Brown</last_name>
      <phone>312-942-6771</phone>
    </contact>
    <investigator>
      <last_name>James Katsis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Lovell</last_name>
      <phone>913-588-6067</phone>
    </contact>
    <investigator>
      <last_name>Kyle Brownback, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Maryland School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cindi Young</last_name>
      <email>cyoung2@som.umaryland.edu</email>
    </contact>
    <investigator>
      <last_name>Van Holden, MD, FCCP</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sally Lu</last_name>
      <phone>410-955-6105</phone>
    </contact>
    <investigator>
      <last_name>Lonny Yarmus, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tatiana Held</last_name>
      <email>THELD@mgh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Erik Folch, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Conley</last_name>
      <phone>617-632-8386</phone>
    </contact>
    <investigator>
      <last_name>Fayez Kheir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lahey Hospital and Medical Center</name>
      <address>
        <city>Burlington</city>
        <state>Massachusetts</state>
        <zip>01805</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Pelletier</last_name>
      <phone>781-744-3706</phone>
    </contact>
    <investigator>
      <last_name>Carla Lamb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Oliver</last_name>
      <phone>906-251-0353</phone>
    </contact>
    <investigator>
      <last_name>Jose Luis De Cardenas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Karlyn Pierson</last_name>
      <email>Pierson.Karlyn@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Darlene Nelson, MD, MHPE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelena Sharp</last_name>
      <phone>601-815-9282</phone>
    </contact>
    <investigator>
      <last_name>Michal Senitko, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Luke's Health System</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosann Gans</last_name>
      <phone>816-932-6122</phone>
    </contact>
    <investigator>
      <last_name>Matthew Aboudara, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Harrison</last_name>
      <phone>314-273-0837</phone>
    </contact>
    <investigator>
      <last_name>Alexander Chen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHI CUMC Bergan Mercy</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68124</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kayleen Joyce</last_name>
      <phone>402-715-4757</phone>
    </contact>
    <investigator>
      <last_name>Suchitra Pilli, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>North Shore - Long Island Jewish Medical Center</name>
      <address>
        <city>Queens</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalie Rajcooar</last_name>
      <phone>516-465-5441</phone>
    </contact>
    <investigator>
      <last_name>Abhinav Agrawal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashley Delgado, BS</last_name>
      <phone>919-349-0496</phone>
    </contact>
    <investigator>
      <last_name>Jason Akulian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Duke University</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathleen Coles</last_name>
      <phone>919-668-3812</phone>
    </contact>
    <investigator>
      <last_name>Momen M Wahidi, MD, MBA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamaal Saleh, BS</last_name>
      <phone>614-366-2258</phone>
    </contact>
    <investigator>
      <last_name>Jasleen Pannu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Pennsylvania State University</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maggie Yoder</last_name>
      <phone>717-531-0003</phone>
      <phone_ext>286789</phone_ext>
    </contact>
    <investigator>
      <last_name>Danish Ahmad, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Andronov</last_name>
      <phone>215-349-8726</phone>
    </contact>
    <investigator>
      <last_name>Kevin C Ma, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Francine McGonagle</last_name>
      <phone>215-707-2682</phone>
    </contact>
    <investigator>
      <last_name>Gerard Criner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lance Roller</last_name>
      <phone>615-875-7313</phone>
    </contact>
    <investigator>
      <last_name>Fabien Maldonado, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kirstie LeDoux</last_name>
      <phone>214-645-6605</phone>
    </contact>
    <investigator>
      <last_name>Muhanned Abu-Hijleh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Rangel</last_name>
      <phone>713-500-6851</phone>
    </contact>
    <investigator>
      <last_name>Pushan Jani, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Weaver</last_name>
      <phone>801-587-7855</phone>
    </contact>
    <investigator>
      <last_name>Sikandar Ansari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>INOVA</name>
      <address>
        <city>Fairfax</city>
        <state>Virginia</state>
        <zip>22031</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dogjin Shin</last_name>
      <phone>703-776-8969</phone>
    </contact>
    <investigator>
      <last_name>Amit Mahajan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Frayser</last_name>
      <phone>804-828-7966</phone>
    </contact>
    <investigator>
      <last_name>Samira Shojaee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James Zelten</last_name>
      <phone>414-955-7494</phone>
    </contact>
    <investigator>
      <last_name>Jonathan Kurman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>November 4, 2019</study_first_submitted>
  <study_first_submitted_qc>November 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2019</study_first_posted>
  <last_update_submitted>August 20, 2021</last_update_submitted>
  <last_update_submitted_qc>August 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pleural Effusion</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

